Article
Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Jun 2018
Xu Chang, Nikolova Olga, Basom Ryan S, Mitchell Ryan M, Shaw Reid, Moser Russell D, Park Heuijoon, Gurley Kay E, Kao Michael C, Green Carlos L, Schaub Franz X, Diaz Robert L, Swan Hallie A, Jang In S, Guinney Justin, Gadi Vijayakrishna K, Margolin Adam A, Grandori Carla, Kemp Christopher J, Méndez Eduardo
Abstract excerpt
Purpose: Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide, with high mortality and a lack of targeted therapies. To identify and prioritize druggable targets, we performed genome analysis together with genome-scale siRNA and oncology drug profiling using low-passage tumor cells derived from a patient with treatment-resistant HPV-negative HNSCC.Experimental Design: A tumor...
Topics
Join the communities discussing this publication.
